Death-Associated Protein Kinase 1 Phosphorylates Pin1 and Inhibits Its Prolyl Isomerase Activity and Cellular Function

Molecular Cell

Volumn 42, Issue 2, 2011, Pages 147-159

  Lee, Tae Ho ^a   Chen, Chun Hau ^a   Suizu, Futoshi ^a,f   Huang, Pengyu ^a   Schiene Fischer, Cordelia ^b   Daum, Sebastian ^b   Zhang, Yan Jessie ^c   Goate, Alison ^d   Chen, Ruey Hwa ^e   Zhou, Xiao Zhen ^a   Lu, Kun Ping ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PROLYL ISOMERASE; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CATALYSIS; CELL EXPANSION; CELL FUNCTION; CELL TRANSFORMATION; CENTROSOME; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ONCOGENE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CATALYTIC DOMAIN; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; ENZYME STABILITY; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MUTATION; NIH 3T3 CELLS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; RECOMBINANT FUSION PROTEINS; SERINE; SIGNAL TRANSDUCTION; TIME FACTORS; TISSUE ARRAY ANALYSIS; TRANSFECTION;

EID: 79954456974     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.03.005     Document Type: Article

References (47)

1. Ayala G., Wang D., Wulf G., Frolov A., Le R., Wheeler T., Sowadski J.M., Lu K.P., Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63:6244-6251.
2. Bao L., Kimzey A., Sauter G., Sowadski J.M., Lu K.P., Wang D.G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
3. Bialik S., Kimchi A. The death-associated protein kinases: structure, function, and beyond. Annu. Rev. Biochem. 2006, 75:189-210.
4. Bialik S., Berissi H., Kimchi A. A high throughput proteomics screen identifies novel substrates of death-associated protein kinase. Mol. Cell. Proteomics 2008, 7:1089-1098.
5. Bovellan M., Fritzsche M., Stevens C., Charras G. Death-associated protein kinase (DAPK) and signal transduction: blebbing in programmed cell death. FEBS J. 2010, 277:58-65.
6. Chen C.H., Wang W.J., Kuo J.C., Tsai H.C., Lin J.R., Chang Z.F., Chen R.H. Bidirectional signals transduced by DAPK-ERK interaction promote the apoptotic effect of DAPK. EMBO J. 2005, 24:294-304.
7. Deiss L.P., Feinstein E., Berissi H., Cohen O., Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev. 1995, 9:15-30.
8. Eckerdt F., Yuan J., Saxena K., Martin B., Kappel S., Lindenau C., Kramer A., Naumann S., Daum S., Fischer G., et al. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 2005, 280:36575-36583.
9. Gossen M., Freundlieb S., Bender G., Müller G., Hillen W., Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995, 268:1766-1769.
10. Inbal B., Cohen O., Polak-Charcon S., Kopolovic J., Vadai E., Eisenbach L., Kimchi A. DAP kinase links the control of apoptosis to metastasis. Nature 1997, 390:180-184.
11. Kuo J.C., Wang W.J., Yao C.C., Wu P.R., Chen R.H. The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway. J. Cell Biol. 2006, 172:619-631.
12. Lee T.H., Tun-Kyi A., Shi R., Lim J., Soohoo C.Y., Finn G., Balastik M., Pastorino L., Wulf G., Zhou X.Z., Lu K.P. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat. Cell Biol. 2009, 11:97-105.
13. Li Y., Grupe A., Rowland C., Nowotny P., Kauwe J.S., Smemo S., Hinrichs A., Tacey K., Toombs T.A., Kwok S., et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum. Mol. Genet. 2006, 15:2560-2568.
14. Liou Y.C., Ryo A., Huang H.K., Lu P.J., Bronson R., Fujimori F., Uchida T., Hunter T., Lu K.P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 2002, 99:1335-1340.
15. Liou Y.-C., Sun A., Ryo A., Zhou X.Z., Yu Z.-X., Huang H.-K., Uchida T., Bronson R., Bing G., Li X., et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424:556-561.
16. Lu K.P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 2003, 4:175-180.
17. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
18. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
19. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
20. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
21. Lu P.J., Zhou X.Z., Liou Y.C., Noel J.P., Lu K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277:2381-2384.
22. Lufei C., Cao X. Nuclear import of Pin1 is mediated by a novel sequence in the PPIase domain. FEBS Lett. 2009, 583:271-276.
23. MacLachlan T.K., Somasundaram K., Sgagias M., Shifman Y., Muschel R.J., Cowan K.H., El-Deiry W.S. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 2000, 275:2777-2785.
24. Michie A.M., McCaig A.M., Nakagawa R., Vukovic M. Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer. FEBS J. 2010, 277:74-80.
25. Pastorino L., Sun A., Lu P.J., Zhou X.Z., Balastik M., Finn G., Wulf G., Lim J., Li S.H., Li X., et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440:528-534.
26. Pike A.C., Rellos P., Niesen F.H., Turnbull A., Oliver A.W., Parker S.A., Turk B.E., Pearl L.H., Knapp S. Activation segment dimerization: a mechanism for kinase autophosphorylation of non-consensus sites. EMBO J. 2008, 27:704-714.
27. Raval A., Tanner S.M., Byrd J.C., Angerman E.B., Perko J.D., Chen S.S., Hackanson B., Grever M.R., Lucas D.M., Matkovic J.J., et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007, 129:879-890.
28. Raveh T., Kimchi A. DAP kinase-a proapoptotic gene that functions as a tumor suppressor. Exp. Cell Res. 2001, 264:185-192.
29. Raveh T., Droguett G., Horwitz M.S., DePinho R.A., Kimchi A. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat. Cell Biol. 2001, 3:1-7.
30. Reineke E.L., Lam M., Liu Q., Liu Y., Stanya K.J., Chang K.S., Means A.R., Kao H.Y. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol. Cell. Biol. 2008, 28:997-1006.
31. Rustighi A., Tiberi L., Soldano A., Napoli M., Nuciforo P., Rosato A., Kaplan F., Capobianco A., Pece S., Di Fiore P.P., Del Sal G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 2009, 11:133-142.
32. Ryo A., Nakamura M., Wulf G., Liou Y.C., Lu K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3:793-801.
33. Ryo A., Liou Y.C., Wulf G., Nakamura M., Lee S.W., Lu K.P. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 2002, 22:5281-5295.
34. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., Rottapel R., Yamaoka S., Lu K.P. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12:1413-1426.
35. Ryo A., Uemura H., Ishiguro H., Saitoh T., Yamaguchi A., Perrem K., Kubota Y., Lu K.P., Aoki I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 2005, 11:7523-7531.
36. Stanya K.J., Liu Y., Means A.R., Kao H.Y. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. J. Cell Biol. 2008, 183:49-61.
37. Suizu F., Ryo A., Wulf G., Lim J., Lu K.P. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol. Cell. Biol. 2006, 26:1463-1479.
38. Tu W., Xu X., Peng L., Zhong X., Zhang W., Soundarapandian M.M., Balel C., Wang M., Jia N., Zhang W., et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010, 140:222-234.
39. Wiegand S., Dakic B., Rath A.F., Makarova G., Sterz C., Meissner W., Bette M., Adamkiewicz J., Müller-Brüsselbach S., Müller R., et al. The rotamase Pin1 is up-regulated, hypophosphorylated and required for cell cycle progression in head and neck squamous cell carcinomas. Oral Oncol. 2009, 45:e140-e149.
40. Winkler K.E., Swenson K.I., Kornbluth S., Means A.R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 2000, 287:1644-1647.
41. Wulf G.M., Ryo A., Wulf G.G., Lee S.W., Niu T., Petkova V., Lu K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20:3459-3472.
42. Wulf G., Garg P., Liou Y.C., Iglehart D., Lu K.P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 2004, 23:3397-3407.
43. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
44. Yeh E.S., Means A.R. PIN1, the cell cycle and cancer. Nat. Rev. Cancer 2007, 7:381-388.
45. Yukawa K., Tanaka T., Bai T., Li L., Tsubota Y., Owada-Makabe K., Maeda M., Hoshino K., Akira S., Iso H. Deletion of the kinase domain from death-associated protein kinase enhances spatial memory in mice. Int. J. Mol. Med. 2006, 17:869-873.
46. Zhang Y., Daum S., Wildemann D., Zhou X.Z., Verdecia M.A., Bowman M.E., Lücke C., Hunter T., Lu K.P., Fischer G., Noel J.P. Structural basis for high-affinity peptide inhibition of human Pin1. ACS Chem. Biol. 2007, 2:320-328.
47. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Küllertz G., Stark M., Fischer G., Lu K.P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.